NICENational Institute forHealth and Care ExcellenceNICE贝guidancePercutaneous transluminal renalsympathetic denervation forresistant hypertensionInterventional procedures guidancePublished:1 March 2023www.nice.org.uk/gquidance/ipg754Your responsibilityThis guidance represents the view of NICE,arrived at after careful consideration of theevidence available.When exercising their judgement,healthcare professionals areexpected to take this guidance fully into account,and specifically any specialarrangements relating to the introduction of new interventional procedures.The guidancedoes not override the individual responsibility of healthcare professionals to makedecisions appropriate to the circumstances of the individual patient,in consultation withthe patient and/or guardian or carer.All problems(adverse events)related to a medicine or medical device used for treatmentor in a procedure should be reported to the Medicines and Healthcare products RegulatoryAgency using the Yellow Card Scheme.Commissioners and/or providers have a responsibility to implement the guidance,in theirlocal context,in light of their duties to have due regard to the need to eliminate unlawfuldiscrimination,advance equality of opportunity,and foster good relations.Nothing in thisNICE 2023.All rights reserved.Subject to Notice of rights (https://www.nice.org.uk/terms-and-Page 1conditions#notice-of-rights).of 6
